Fractyl Health (GUTS) Net Income towards Common Stockholders (2023 - 2026)

Fractyl Health (GUTS) has 4 years of Net Income towards Common Stockholders data on file, last reported at -$20.2 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 14.78% year-over-year to -$20.2 million; the trailing twelve-month figure through Mar 2026 stood at -$137.4 million (down 54.25% YoY), and the FY2025 full-year result was -$141.0 million, down 100.13% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$20.2 million, up from -$43.7 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at -$5.1 million in Q1 2024 and bottomed at -$45.6 million in Q3 2025.
• A 4-year average of -$25.1 million and a median of -$23.5 million in 2023 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders jumped 68.71% in 2024 and plunged 369.16% in 2025, its largest moves.
• Tracing GUTS's Net Income towards Common Stockholders over 4 years: stood at -$23.5 million in 2023, then declined by 6.21% to -$25.0 million in 2024, then sank by 75.12% to -$43.7 million in 2025, then jumped by 53.74% to -$20.2 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$20.2 million, -$43.7 million, and -$45.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison